The $650 million acquisition of AI-powered patient engagement and payments platform Weave by global investment firm Francisco Partners has been completed.
Under the terms of the deal, Weave stockholders will receive $7.40 per share in cash, representing a premium of approximately 34% to Weave’s unaffected closing stock price on August 17, 2026.
With the deal's completion, Weave’s common stock has ceased trading and is no longer listed on the New York Stock Exchange.
The company will continue operating as a privately held company under the Weave name and maintain its headquarters in Lehi, UT.
